share_log

国药控股(01099.HK)获摩根大通增持132.7万股

Sinopharm Holdings (01099.HK) received 1.377 million shares from J.P. Morgan Chase

Gelonghui Finance ·  May 8 07:27

Gelonghui, May 8 | According to the latest equity disclosure data from the Stock Exchange, on April 30, 2024, Sinopharm Holdings (01099.HK) obtained JPMorgan Chase & Co. increased its position by 1.37,000 shares at an average price of HK$20.0142 per share, involving approximately HK$26.559 million.

After the increase in holdings, JPMorgan Chase & Co.'s latest number of positions was 81.0281 million shares, and the holding ratio increased from 5.93% to 6.03%.

Big

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment